ImmunoPrecise Antibodies Ltd. ( NASDAQ: IPA) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - Interim Chief ...

A bioengineer highlights the potential of low-intensity ultrasound for multiple uses, from enhanced drug delivery to the ...

The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, ...

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...

Discover why protein is considered the superstar nutrient for weight management and learn how much you need daily to maximize ...

A Skills Development and Productivity Enhancement Project, Post COVID-19 Skills Development and Productivity Enhancement ...

Alan Herbert, explores the understanding of genome information storage, and the significance of repetitive sequences called ...

Haemolytic disease of the fetus and newborn (HDFN) occurs when there is transplacental passage of maternal immunoglobulin G ...

The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, ...

Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial ...